Scott B. Kozak, MBA; Chairman & Chief Executive Officer

Mr. Kozak has a MBA in Marketing & International Business, 25 years international pharmaceutical and life sciences experience (Solvay, Hoffmann La Roche, Forest Labs), including sales, marketing, corporate licensing, business development, alliance management, patent portfolio management and M&A experience.

Philip J. Barr, PhD; Co-founder, President and Chief Scientific Officer

Dr. Barr holds a PhD in organic chemistry, and has over 30 years of experience in commercial chemistry and molecular biology. He was the primary editor of the first book on commercial yeast genetic engineering, and has over 50 issued patents, 200 papers and book chapters in chemistry, molecular biology and genetic engineering of industrial microorganisms.  He is the former Director of Molecular Biology at Chiron Corporation (since acquired by Novartis), Founder, CSO and CEO of Arriva Pharmaceuticals, Inc., and was an Adjunct Professor of Chemistry at the University of California, San Francisco for over 25 years.

Jianping Sun, PhD; Senior Scientist, Molecular Biology and Fermentation

Dr. Sun has a PhD in biochemistry and molecular biology from the University of Science and Technology of China.  She also has several years of research experience in academia, including postdoctoral studies at the University of California, Berkeley Energy Biosciences Institute.  In addition to fermentation expertise, Dr. Sun has experience in industrial metabolic engineering and systems biology through a previous position at Intrexon Corporation.